TABLE OF CONTENTS
Volume 28, Issue 14 (9 April 2009)
Review
The SWI/SNF complex and cancer
D Reisman, S Glaros and E A Thompson
Oncogene 28: 1653-1668; advance online publication, February 23, 2009; doi:10.1038/onc.2009.4
Original Articles
Jak2 inhibition deactivates Lyn kinase through the SET–PP2A–SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients
A K Samanta, S N Chakraborty, Y Wang, H Kantarjian, X Sun, J Hood, D Perrotti and R B Arlinghaus
Oncogene 28: 1669-1681; advance online publication, February 23, 2009; doi:10.1038/onc.2009.7
Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells
G Tilman, A Loriot, A Van Beneden, N Arnoult, J A Londoño-Vallejo, C De Smet and A Decottignies
Oncogene 28: 1682-1693; advance online publication, March 2, 2009; doi:10.1038/onc.2009.23
VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo
C M Lee, M M Hickey, C A Sanford, C G McGuire, C L Cowey, M C Simon and W K Rathmell
Oncogene 28: 1694-1705; advance online publication, March 2, 2009; doi:10.1038/onc.2009.12
EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells
B P Fox and R P Kandpal
Oncogene 28: 1706-1713; advance online publication, February 23, 2009; doi:10.1038/onc.2009.18
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer
E J Noonan, R F Place, D Pookot, S Basak, J M Whitson, H Hirata, C Giardina and R Dahiya
Oncogene 28: 1714-1724; advance online publication, March 2, 2009; doi:10.1038/onc.2009.19
Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration
K Endo, S Kondo, J Shackleford, T Horikawa, N Kitagawa, T Yoshizaki, M Furukawa, Y Zen and J S Pagano
Oncogene 28: 1725-1735; advance online publication, February 23, 2009; doi:10.1038/onc.2009.20
